Traction you can audit,
results we're measuring.

Two evidence streams converging on the Aug 31 close — early-adopter traction and the 14-day beta trial currently in progress.

3

Pilot cohorts

Cert

Third-party in progress

100%

Third-party tested · COAs published

Aug 31

Target raise close

Stream 01

LIVE

Early-adopter traction

Quantified-self early adopters — HRV monitors, sleep trackers, continuous glucose users — are the first cohort. They read every label and reorder based on measurable results.

  • ✓3 pilot cohorts · reorder intent confirmed
  • ✓Retention and adherence tracked across cohorts
  • ✓Expansion pipeline across wellness channels

Stream 02

REPORTING SOON

14-day beta trial

A 14-day structured trial with working professionals tracking wearable health metrics before and after daily Statia use.

Sleep-onset latency— —
Stress-recovery composite— —
HRV readiness delta— —
14-day adherence— —

Protocol: daily single-serve dose, 14 days, wearable-tracked metrics (HRV, sleep latency, stress-recovery index), self-reported adherence.

Request the data room.

Full financials, traction data, and beta trial protocol.

Request the data room